HEADER TRANSFERASE 02-DEC-20 7B43 TITLE CRYSTAL STRUCTURE OF C-MET BOUND BY COMPOUND 9 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HGF RECEPTOR,HGF/SF RECEPTOR,PROTO-ONCOGENE C-MET,SCATTER COMPND 5 FACTOR RECEPTOR,SF RECEPTOR,TYROSINE-PROTEIN KINASE MET; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS C-MET, KINASE, FOLDED P-LOOP, INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR G.W.COLLIE REVDAT 4 01-MAY-24 7B43 1 REMARK REVDAT 3 03-FEB-21 7B43 1 JRNL REVDAT 2 23-DEC-20 7B43 1 JRNL REVDAT 1 09-DEC-20 7B43 0 JRNL AUTH G.W.COLLIE,I.N.MICHAELIDES,K.EMBREY,C.J.STUBBS,U.BORJESSON, JRNL AUTH 2 I.L.DALE,A.SNIJDER,L.BARLIND,K.SONG,P.KHURANA,C.PHILLIPS, JRNL AUTH 3 R.I.STORER JRNL TITL STRUCTURAL BASIS FOR TARGETING THE FOLDED P-LOOP JRNL TITL 2 CONFORMATION OF C-MET. JRNL REF ACS MED.CHEM.LETT. V. 12 162 2021 JRNL REFN ISSN 1948-5875 JRNL PMID 33488978 JRNL DOI 10.1021/ACSMEDCHEMLETT.0C00392 REMARK 2 REMARK 2 RESOLUTION. 1.87 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.87 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 18.41 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 51.4 REMARK 3 NUMBER OF REFLECTIONS : 28882 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.790 REMARK 3 FREE R VALUE TEST SET COUNT : 1384 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 50 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.87 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.96 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 8.14 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 578 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2236 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 549 REMARK 3 BIN R VALUE (WORKING SET) : 0.2199 REMARK 3 BIN FREE R VALUE : 0.2864 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.02 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 29 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4307 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 128 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.59 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.98540 REMARK 3 B22 (A**2) : 0.32230 REMARK 3 B33 (A**2) : 0.66320 REMARK 3 B12 (A**2) : -0.11810 REMARK 3 B13 (A**2) : -0.29940 REMARK 3 B23 (A**2) : 0.20120 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.310 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.278 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.219 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.298 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.227 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.921 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.871 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4481 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6092 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1478 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 729 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4481 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 574 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5266 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.02 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.66 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.23 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7B43 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-DEC-20. REMARK 100 THE DEPOSITION ID IS D_1292112613. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-SEP-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00001 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28964 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.870 REMARK 200 RESOLUTION RANGE LOW (A) : 73.706 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 70.0 REMARK 200 DATA REDUNDANCY : 2.700 REMARK 200 R MERGE (I) : 0.10900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 3.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.87 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 34.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : 0.51200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: INTERNAL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.91 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.61 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 28 % PEGMME2000, 0.1 M BIS-TRIS PH REMARK 280 6.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1048 REMARK 465 ASN A 1049 REMARK 465 THR A 1050 REMARK 465 VAL A 1051 REMARK 465 HIS A 1052 REMARK 465 ILE A 1053 REMARK 465 ASP A 1054 REMARK 465 ARG A 1148 REMARK 465 SER A 1149 REMARK 465 GLU A 1150 REMARK 465 SER A 1236 REMARK 465 VAL A 1237 REMARK 465 HIS A 1238 REMARK 465 ASN A 1239 REMARK 465 LYS A 1240 REMARK 465 THR A 1241 REMARK 465 GLY A 1242 REMARK 465 ALA A 1243 REMARK 465 LYS A 1244 REMARK 465 LEU A 1245 REMARK 465 ILE A 1345 REMARK 465 GLY A 1346 REMARK 465 GLY B 1048 REMARK 465 ASN B 1049 REMARK 465 THR B 1050 REMARK 465 VAL B 1051 REMARK 465 HIS B 1052 REMARK 465 ILE B 1053 REMARK 465 ASP B 1054 REMARK 465 ARG B 1148 REMARK 465 SER B 1149 REMARK 465 GLU B 1150 REMARK 465 GLY B 1151 REMARK 465 SER B 1236 REMARK 465 VAL B 1237 REMARK 465 HIS B 1238 REMARK 465 ASN B 1239 REMARK 465 LYS B 1240 REMARK 465 THR B 1241 REMARK 465 GLY B 1242 REMARK 465 ALA B 1243 REMARK 465 LYS B 1244 REMARK 465 LEU B 1245 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A1061 CG CD OE1 OE2 REMARK 470 ASP A1101 CG OD1 OD2 REMARK 470 LYS A1103 CG CD CE NZ REMARK 470 ARG A1114 CG CD NE CZ NH1 NH2 REMARK 470 GLU A1120 CG CD OE1 OE2 REMARK 470 GLU A1172 CG CD OE1 OE2 REMARK 470 LYS A1232 CG CD CE NZ REMARK 470 GLU A1233 CG CD OE1 OE2 REMARK 470 LYS A1259 CE NZ REMARK 470 LYS A1263 CG CD CE NZ REMARK 470 ARG A1279 CG CD NE CZ NH1 NH2 REMARK 470 GLU A1314 CG CD OE1 OE2 REMARK 470 GLU A1332 CG CD OE1 OE2 REMARK 470 ARG B1086 CZ NH1 NH2 REMARK 470 LYS B1103 CG CD CE NZ REMARK 470 ARG B1114 CG CD NE CZ NH1 NH2 REMARK 470 GLN B1123 CG CD OE1 NE2 REMARK 470 ASN B1171 CG OD1 ND2 REMARK 470 GLU B1172 CG CD OE1 OE2 REMARK 470 LYS B1199 CG CD CE NZ REMARK 470 ARG B1208 NE CZ NH1 NH2 REMARK 470 LYS B1215 CG CD CE NZ REMARK 470 LYS B1232 CG CD CE NZ REMARK 470 GLU B1233 CG CD OE1 OE2 REMARK 470 LYS B1259 CG CD CE NZ REMARK 470 ARG B1300 NE CZ NH1 NH2 REMARK 470 GLU B1306 CG CD OE1 OE2 REMARK 470 GLU B1314 CG CD OE1 OE2 REMARK 470 LYS B1323 CG CD CE NZ REMARK 470 GLU B1332 CG CD OE1 OE2 REMARK 470 GLY B1346 C O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A1086 38.22 38.53 REMARK 500 ARG A1203 -13.55 73.61 REMARK 500 ASP A1204 53.23 -146.68 REMARK 500 ALA A1221 -157.56 -126.09 REMARK 500 TYR A1230 64.19 -105.42 REMARK 500 ASP A1231 78.49 -110.70 REMARK 500 TYR A1307 41.58 -97.46 REMARK 500 ARG B1203 -23.91 82.35 REMARK 500 ALA B1221 -160.72 -125.04 REMARK 500 SER B1342 2.99 -64.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SW5 A 1401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SW5 B 1401 DBREF 7B43 A 1049 1346 UNP P08581 MET_HUMAN 1049 1346 DBREF 7B43 B 1049 1346 UNP P08581 MET_HUMAN 1049 1346 SEQADV 7B43 GLY A 1048 UNP P08581 EXPRESSION TAG SEQADV 7B43 GLY B 1048 UNP P08581 EXPRESSION TAG SEQRES 1 A 299 GLY ASN THR VAL HIS ILE ASP LEU SER ALA LEU ASN PRO SEQRES 2 A 299 GLU LEU VAL GLN ALA VAL GLN HIS VAL VAL ILE GLY PRO SEQRES 3 A 299 SER SER LEU ILE VAL HIS PHE ASN GLU VAL ILE GLY ARG SEQRES 4 A 299 GLY HIS PHE GLY CYS VAL TYR HIS GLY THR LEU LEU ASP SEQRES 5 A 299 ASN ASP GLY LYS LYS ILE HIS CYS ALA VAL LYS SER LEU SEQRES 6 A 299 ASN ARG ILE THR ASP ILE GLY GLU VAL SER GLN PHE LEU SEQRES 7 A 299 THR GLU GLY ILE ILE MET LYS ASP PHE SER HIS PRO ASN SEQRES 8 A 299 VAL LEU SER LEU LEU GLY ILE CYS LEU ARG SER GLU GLY SEQRES 9 A 299 SER PRO LEU VAL VAL LEU PRO TYR MET LYS HIS GLY ASP SEQRES 10 A 299 LEU ARG ASN PHE ILE ARG ASN GLU THR HIS ASN PRO THR SEQRES 11 A 299 VAL LYS ASP LEU ILE GLY PHE GLY LEU GLN VAL ALA LYS SEQRES 12 A 299 GLY MET LYS TYR LEU ALA SER LYS LYS PHE VAL HIS ARG SEQRES 13 A 299 ASP LEU ALA ALA ARG ASN CYS MET LEU ASP GLU LYS PHE SEQRES 14 A 299 THR VAL LYS VAL ALA ASP PHE GLY LEU ALA ARG ASP MET SEQRES 15 A 299 TYR ASP LYS GLU TYR TYR SER VAL HIS ASN LYS THR GLY SEQRES 16 A 299 ALA LYS LEU PRO VAL LYS TRP MET ALA LEU GLU SER LEU SEQRES 17 A 299 GLN THR GLN LYS PHE THR THR LYS SER ASP VAL TRP SER SEQRES 18 A 299 PHE GLY VAL LEU LEU TRP GLU LEU MET THR ARG GLY ALA SEQRES 19 A 299 PRO PRO TYR PRO ASP VAL ASN THR PHE ASP ILE THR VAL SEQRES 20 A 299 TYR LEU LEU GLN GLY ARG ARG LEU LEU GLN PRO GLU TYR SEQRES 21 A 299 CYS PRO ASP PRO LEU TYR GLU VAL MET LEU LYS CYS TRP SEQRES 22 A 299 HIS PRO LYS ALA GLU MET ARG PRO SER PHE SER GLU LEU SEQRES 23 A 299 VAL SER ARG ILE SER ALA ILE PHE SER THR PHE ILE GLY SEQRES 1 B 299 GLY ASN THR VAL HIS ILE ASP LEU SER ALA LEU ASN PRO SEQRES 2 B 299 GLU LEU VAL GLN ALA VAL GLN HIS VAL VAL ILE GLY PRO SEQRES 3 B 299 SER SER LEU ILE VAL HIS PHE ASN GLU VAL ILE GLY ARG SEQRES 4 B 299 GLY HIS PHE GLY CYS VAL TYR HIS GLY THR LEU LEU ASP SEQRES 5 B 299 ASN ASP GLY LYS LYS ILE HIS CYS ALA VAL LYS SER LEU SEQRES 6 B 299 ASN ARG ILE THR ASP ILE GLY GLU VAL SER GLN PHE LEU SEQRES 7 B 299 THR GLU GLY ILE ILE MET LYS ASP PHE SER HIS PRO ASN SEQRES 8 B 299 VAL LEU SER LEU LEU GLY ILE CYS LEU ARG SER GLU GLY SEQRES 9 B 299 SER PRO LEU VAL VAL LEU PRO TYR MET LYS HIS GLY ASP SEQRES 10 B 299 LEU ARG ASN PHE ILE ARG ASN GLU THR HIS ASN PRO THR SEQRES 11 B 299 VAL LYS ASP LEU ILE GLY PHE GLY LEU GLN VAL ALA LYS SEQRES 12 B 299 GLY MET LYS TYR LEU ALA SER LYS LYS PHE VAL HIS ARG SEQRES 13 B 299 ASP LEU ALA ALA ARG ASN CYS MET LEU ASP GLU LYS PHE SEQRES 14 B 299 THR VAL LYS VAL ALA ASP PHE GLY LEU ALA ARG ASP MET SEQRES 15 B 299 TYR ASP LYS GLU TYR TYR SER VAL HIS ASN LYS THR GLY SEQRES 16 B 299 ALA LYS LEU PRO VAL LYS TRP MET ALA LEU GLU SER LEU SEQRES 17 B 299 GLN THR GLN LYS PHE THR THR LYS SER ASP VAL TRP SER SEQRES 18 B 299 PHE GLY VAL LEU LEU TRP GLU LEU MET THR ARG GLY ALA SEQRES 19 B 299 PRO PRO TYR PRO ASP VAL ASN THR PHE ASP ILE THR VAL SEQRES 20 B 299 TYR LEU LEU GLN GLY ARG ARG LEU LEU GLN PRO GLU TYR SEQRES 21 B 299 CYS PRO ASP PRO LEU TYR GLU VAL MET LEU LYS CYS TRP SEQRES 22 B 299 HIS PRO LYS ALA GLU MET ARG PRO SER PHE SER GLU LEU SEQRES 23 B 299 VAL SER ARG ILE SER ALA ILE PHE SER THR PHE ILE GLY HET SW5 A1401 28 HET SW5 B1401 28 HETNAM SW5 3-[(4-FLUOROPHENYL)METHYL]-5-(1-PIPERIDIN-4-YLPYRAZOL- HETNAM 2 SW5 4-YL)-1~{H}-PYRROLO[2,3-B]PYRIDINE FORMUL 3 SW5 2(C22 H22 F N5) FORMUL 5 HOH *128(H2 O) HELIX 1 AA1 ASN A 1059 GLN A 1067 1 9 HELIX 2 AA2 HIS A 1068 VAL A 1070 5 3 HELIX 3 AA3 GLY A 1072 SER A 1074 5 3 HELIX 4 AA4 GLY A 1085 HIS A 1088 5 4 HELIX 5 AA5 ASP A 1117 ASP A 1133 1 17 HELIX 6 AA6 LEU A 1165 ASN A 1171 1 7 HELIX 7 AA7 THR A 1177 LYS A 1198 1 22 HELIX 8 AA8 ALA A 1206 ARG A 1208 5 3 HELIX 9 AA9 PHE A 1223 ARG A 1227 5 5 HELIX 10 AB1 ALA A 1251 GLN A 1258 1 8 HELIX 11 AB2 THR A 1261 THR A 1278 1 18 HELIX 12 AB3 ASP A 1291 GLN A 1298 1 8 HELIX 13 AB4 PRO A 1309 TRP A 1320 1 12 HELIX 14 AB5 LYS A 1323 ARG A 1327 5 5 HELIX 15 AB6 SER A 1329 SER A 1342 1 14 HELIX 16 AB7 ASN B 1059 GLN B 1067 1 9 HELIX 17 AB8 GLY B 1085 HIS B 1088 5 4 HELIX 18 AB9 ASP B 1117 ASP B 1133 1 17 HELIX 19 AC1 LEU B 1165 ASN B 1171 1 7 HELIX 20 AC2 THR B 1177 LYS B 1198 1 22 HELIX 21 AC3 ALA B 1206 ARG B 1208 5 3 HELIX 22 AC4 PHE B 1223 ARG B 1227 5 5 HELIX 23 AC5 PRO B 1246 MET B 1250 5 5 HELIX 24 AC6 ALA B 1251 GLN B 1258 1 8 HELIX 25 AC7 THR B 1261 THR B 1278 1 18 HELIX 26 AC8 ASP B 1291 GLN B 1298 1 8 HELIX 27 AC9 PRO B 1309 TRP B 1320 1 12 HELIX 28 AD1 LYS B 1323 ARG B 1327 5 5 HELIX 29 AD2 SER B 1329 SER B 1342 1 14 SHEET 1 AA1 5 LEU A1076 VAL A1083 0 SHEET 2 AA1 5 VAL A1092 LEU A1098 -1 O THR A1096 N ILE A1077 SHEET 3 AA1 5 LYS A1104 SER A1111 -1 O VAL A1109 N TYR A1093 SHEET 4 AA1 5 LEU A1154 PRO A1158 -1 O LEU A1157 N ALA A1108 SHEET 5 AA1 5 GLY A1144 CYS A1146 -1 N GLY A1144 O VAL A1156 SHEET 1 AA2 3 GLY A1163 ASP A1164 0 SHEET 2 AA2 3 CYS A1210 LEU A1212 -1 O LEU A1212 N GLY A1163 SHEET 3 AA2 3 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SHEET 1 AA3 5 LEU B1076 VAL B1083 0 SHEET 2 AA3 5 VAL B1092 LEU B1098 -1 O THR B1096 N ILE B1077 SHEET 3 AA3 5 LYS B1104 SER B1111 -1 O VAL B1109 N TYR B1093 SHEET 4 AA3 5 LEU B1154 PRO B1158 -1 O LEU B1157 N ALA B1108 SHEET 5 AA3 5 GLY B1144 CYS B1146 -1 N GLY B1144 O VAL B1156 SHEET 1 AA4 3 GLY B1163 ASP B1164 0 SHEET 2 AA4 3 CYS B1210 LEU B1212 -1 O LEU B1212 N GLY B1163 SHEET 3 AA4 3 VAL B1218 VAL B1220 -1 O LYS B1219 N MET B1211 SITE 1 AC1 17 ILE A1084 GLY A1085 PHE A1089 VAL A1092 SITE 2 AC1 17 ALA A1108 LYS A1110 LEU A1157 PRO A1158 SITE 3 AC1 17 TYR A1159 MET A1160 LYS A1161 GLY A1163 SITE 4 AC1 17 MET A1211 LEU A1225 ALA A1226 MET A1229 SITE 5 AC1 17 HOH A1529 SITE 1 AC2 16 ILE B1084 PHE B1089 VAL B1092 ALA B1108 SITE 2 AC2 16 LYS B1110 LEU B1157 PRO B1158 TYR B1159 SITE 3 AC2 16 MET B1160 LYS B1161 HIS B1162 MET B1211 SITE 4 AC2 16 LEU B1225 ALA B1226 MET B1229 HOH B1543 CRYST1 42.867 59.738 77.603 76.51 73.88 69.25 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023328 -0.008838 -0.005477 0.00000 SCALE2 0.000000 0.017901 -0.002719 0.00000 SCALE3 0.000000 0.000000 0.013567 0.00000